Jonathan Jay Mazelsky
CEO, President at Idexx Laboratories Inc /De (IDXX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $15.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,281 | $650.67 | $834K | -19.0% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,095 | $651.49 | $713K | -19.1% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,669 | $652.49 | $1.1M | -19.2% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,171 | $653.68 | $765K | -19.4% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,111 | $654.63 | $727K | -19.5% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,488 | $655.85 | $976K | -19.6% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,343 | $656.85 | $882K | -19.8% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 2,860 | $657.84 | $1.9M | -19.9% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 3,660 | $658.92 | $2.4M | -20.0% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 2,859 | $659.75 | $1.9M | -20.1% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,200 | $661.10 | $793K | -20.3% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 1,000 | $662.16 | $662K | -20.4% |
| Mar 2SEC | IDXXIdexx Laboratories Inc /De | Sell | 2,589 | $663.04 | $1.7M | -20.5% |